Amy Harms manages the Metabolomics Core Facility at Leiden University, embedded in the Analytical Biosciences division of the LACDR. She received her PhD in chemistry from Penn State in 1994 and did post-doctoral research in the field of biological mass spectrometry at Pacific Northwest National Lab. After working as a mass spectrometry facility manager in the University of Kentucky, she moved to Wisconsin and in 1998 became the director of the Mass Spectrometry/ proteomics/ metabolomics facility at the University of Wisconsin Biotechnology Center and ran the core facility for the University of Wisconsin Comprehensive Cancer Center until moving to the Netherlands.
Amy’s interests include instrumentation, data processing strategies, and quality control. As research support, she hopes to contribute to the experimental design, the actual collecting of data, evaluation and interpretation of data, and integration of metabolomics into the larger goals of the proposed projects.
Exposome-NL is a Dutch consortium of over fifty scientists from different disciplines, universities and medical centres. Together the scientists will systematically sequence the environmental factors influencing our health.Read More